Torqur
Phase 2Each cancer treatment remains a case-by-case battle, with a limited panel of therapeutic options available. Considering the relatively low response of cancer patients to standards of care that are effective only in a narrow subset of patients, there is a tremendous need for new targeted therapies.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Each cancer treatment remains a case-by-case battle, with a limited panel of therapeutic options available. Considering the relatively low response of cancer patients to standards of care that are effective only in a narrow subset of patients, there is a tremendous need for new targeted therapies.
Small Molecules